DNA Sequencing Systems, Arrays Drive 8 Percent Growth for Roche Applied Science in First Half of '09
July 28, 2009
DNA Sequencing Systems, Arrays Drive 8 Percent Growth for Roche Applied Science in First Half of '09
The 454 GS FLX platform and NimbleGen microarrays "continue to drive growth" of Roche's Applied Science business, "delivering robust double-digit sales increases."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche's Sequencing and Array Sales Grow 10 Percent Combined in H1
July 27, 2010 / In Sequence - Roche, Fluidigm Ink Deal to Co-market Access Array Platform with 454 Sequencing
October 19, 2010 / BioArray News - In Applied Science Restructuring, Roche Exits Microarrays, Bundles 'Sequencing Solutions,' R&D
June 12, 2012 / In Sequence - Illumina Issues Second Shareholder Letter to Reject Roche
March 26, 2012 / GenomeWeb Daily News - FTC Requests Additional Information From Roche Related to Illumina Bid
March 14, 2012 / GenomeWeb Daily News